BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18485087)

  • 1. Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura.
    Gardiner EE; Al-Tamimi M; Mu FT; Karunakaran D; Thom JY; Moroi M; Andrews RK; Berndt MC; Baker RI
    J Thromb Haemost; 2008 Jul; 6(7):1175-82. PubMed ID: 18485087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface.
    Boylan B; Chen H; Rathore V; Paddock C; Salacz M; Friedman KD; Curtis BR; Stapleton M; Newman DK; Kahn ML; Newman PJ
    Blood; 2004 Sep; 104(5):1350-5. PubMed ID: 15150079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa.
    Gardiner EE; Karunakaran D; Arthur JF; Mu FT; Powell MS; Baker RI; Hogarth PM; Kahn ML; Andrews RK; Berndt MC
    Blood; 2008 Jan; 111(1):165-74. PubMed ID: 17848620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
    Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
    Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis.
    Nurden P; Tandon N; Takizawa H; Couzi L; Morel D; Fiore M; Pillois X; Loyau S; Jandrot-Perrus M; Nurden AT
    J Thromb Haemost; 2009 Sep; 7(9):1541-9. PubMed ID: 19583823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of platelet-associated anti-glycoprotein (GP)VI autoantibodies and restoration of GPVI expression in patients with GPVI deficiency.
    Akiyama M; Kashiwagi H; Todo K; Moroi M; Berndt MC; Kojima H; Kanakura Y; Tomiyama Y
    J Thromb Haemost; 2009 Aug; 7(8):1373-83. PubMed ID: 19522742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human platelet glycoprotein VI-specific IgG autoantibody and its fragments.
    Chu X; Hou M; Peng J; Zhu Y; Zhang F; Ji X; Wang L; Ma D
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):403-7. PubMed ID: 16788317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of a humanized inhibitory anti-platelet glycoprotein VI phage antibody from a phage antibody library.
    Liu Q; Zhang C; Yu L; Shi Y; Zhang L; Peng J; Ji X; Hou M
    Hematology; 2016 Jan; 21(1):60-7. PubMed ID: 26330203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of human platelet specific functional antibody and its fragments].
    Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway.
    Dunkley S; Arthur JF; Evans S; Gardiner EE; Shen Y; Andrews RK
    Br J Haematol; 2007 Jun; 137(6):569-77. PubMed ID: 17539777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a patient with glycoprotein (GP) VI deficiency possessing neither anti-GPVI autoantibody nor genetic aberration.
    Kojima H; Moroi M; Jung SM; Goto S; Tamura N; Kozuma Y; Suzukawa K; Nagasawa T
    J Thromb Haemost; 2006 Nov; 4(11):2433-42. PubMed ID: 17059472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia.
    Hardy AT; Palma-Barqueros V; Watson SK; Malcor JD; Eble JA; Gardiner EE; Blanco JE; Guijarro-Campillo R; Delgado JL; Lozano ML; Teruel-Montoya R; Vicente V; Watson SP; Rivera J; Ferrer-MarĂ­n F
    Thromb Haemost; 2018 Jun; 118(6):1009-1020. PubMed ID: 29695020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effect of eltrombopag therapy on the platelet collagen receptor glycoprotein VI (GPVI) expression and soluble GPVI levels in young patients with immune thrombocytopenia.
    Tantawy AAG; Elsherif NHK; Ebeid FS; El-Gamal RAE; Ismail EAR; Kenny MA; Morcos MBE
    J Thromb Thrombolysis; 2023 Feb; 55(2):243-251. PubMed ID: 36479670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients.
    Karpatkin S; Nardi MA; Hymes KB
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2263-7. PubMed ID: 7892259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring soluble platelet glycoprotein VI in human plasma by ELISA.
    Al-Tamimi M; Mu FT; Moroi M; Gardiner EE; Berndt MC; Andrews RK
    Platelets; 2009 May; 20(3):143-9. PubMed ID: 19437330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura.
    He R; Reid DM; Jones CE; Shulman NR
    Blood; 1994 Feb; 83(4):1024-32. PubMed ID: 8111044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro.
    Chang M; Nakagawa PA; Williams SA; Schwartz MR; Imfeld KL; Buzby JS; Nugent DJ
    Blood; 2003 Aug; 102(3):887-95. PubMed ID: 12676790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLEC-2 expression is maintained on activated platelets and on platelet microparticles.
    Gitz E; Pollitt AY; Gitz-Francois JJ; Alshehri O; Mori J; Montague S; Nash GB; Douglas MR; Gardiner EE; Andrews RK; Buckley CD; Harrison P; Watson SP
    Blood; 2014 Oct; 124(14):2262-70. PubMed ID: 25150298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune antibody in a patient with idiopathic thrombocytopenic purpura reacted to the platelet low molecular weight glycoproteins and activated platelets.
    Hashimoto Y; Tanabe J; Mohri H; Ohkubo T
    Am J Clin Pathol; 1994 Mar; 101(3):370-4. PubMed ID: 8135199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpura.
    Yanabu M; Nomura S; Fukuroi T; Suzuki M; Kawakatsu T; Kido H; Yamaguchi K; Kokawa T; Yasunaga K
    Br J Haematol; 1993 Aug; 84(4):694-701. PubMed ID: 8217830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.